|
1
|
Abbvie Pty Ltd
|
|
2
|
Associate Professor Ian Haines
|
|
3
|
Dr Mary Osborn
|
|
4
|
Dr Ken Harvey
|
|
5
|
SANOFI
|
|
6
|
Medical Technology Association of Australia and IVD
Australia
|
|
7
|
Australian Medical Association
|
|
8
|
Pfizer Australia
|
|
9
|
Vifor Pharma
|
|
10
|
MSD
|
|
11
|
Amgen Australia Pty Ltd
|
|
12
|
Allergan Australia Pty Ltd
|
|
13
|
Lundbeck Australia Pty Ltd
|
|
14
|
Consumers Health Forum of Australia
|
|
15
|
Janssen-Cilag Pty Ltd
|
|
16
|
Medicines Australia
|
|
17
|
GlaxoSmithKline
|
|
18
|
Merck Serono
|
|
19
|
Australian Self-Medication Industry Inc
|
|
20
|
GMiA (Generic Medicines Industry Association Pty
Ltd)
|
|
21
|
Bristol-Myers Squibb
|
|
22
|
Abbott Australasia Pty Ltd
|
|
23
|
University of Sydney
|
|
24
|
Department of Health and Ageing
|
|
25
|
Australian Dental Industry Association
|
| |
|
| Tabled Documents |
|
1
|
Dr Ken Harvey, Opening statement, tabled at public
hearing, 29 April 2013
|
|
2
|
Dr Ken Harvey, Media article "U.S. sues
Novartis over kickbacks", tabled at public hearing, 29 April 2013
|
|
3
|
Dr Ken Harvey, "The Great Pill Pu$h: Tracking
the marketing of medicines in Australia", The Global Mail, tabled
at public hearing, 29 April 2013
|
|
4
|
GlaxoSmithKline, Opening statement, tabled at public
hearing, 29 April 2013
|
|
5
|
Medicines Australia, Code of Conduct (edition 17),
tabled at public hearing, 29 April 2013
|
| |
|
| Answers to Questions on Notice |
|
1
|
Answer to Question on
Notice, GlaxoSmithKline, 29 April 2013, received 30 April 2013
|
|
2
|
Answer to Question on
Notice, Department of Health and Ageing, 29 April 2013, received 22 May 2013
|
|
3
|
Answer to Question on
Notice, Department of Health and Ageing, 29 April 2013, received 22 May 2013
|
|
4
|
Answer to Question on
Notice, Department of Health and Ageing, 29 April 2013, received 22 May 2013
|